Publication
Global rules on foreign direct investment (FDI)
Cross-border acquisitions and investments increasingly trigger foreign direct investment (FDI) screening requirements.
Global | Publication | January 2019
On December 20, Health Canada announced the opening of its consultation period on the regulations that will allow cannabis edibles, extracts and topicals to be sold in Canada. This consultation represents the next significant step in Canada’s cannabis legalization effort. Along with the consultation comes draft regulations that will give industry an opportunity to get an idea of the requirements they will need to meet. The draft regulations along with the Regulatory Impact Analysis Statement weigh in at a hefty 195 pages. Here are some of the key details.
Product | THC per “discrete unit” (e.g. one edible or one vape cartridge) | Total THC per package |
Edibles | 10 mg | 10 mg |
Extracts | 10 mg | 1000 mg |
Topicals | N/A | 1000 mg |
Health Canada will be accepting comments on the proposed regulations until February 20, 2019. The federal government is targeting October 17, 2019, as the date on which the new regulations will go into effect.
The author wishes to thank articling student Daniel Weiss for his help in preparing this legal update.
Publication
Cross-border acquisitions and investments increasingly trigger foreign direct investment (FDI) screening requirements.
Publication
The EU’s Artificial Intelligence Regulation, commonly referred to as the AI Act, is expected to come into force during the summer of 2024 (the AI Act). The AI Act will be the first comprehensive legal framework for the use and development of artificial intelligence (AI), and is intended to ensure that AI systems developed and used in the EU are safe, transparent, traceable, non-discriminatory and environmentally friendly.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023